Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at jsummers@usagainstalzheimers.org.

  • August 27, 2024

    Great Britain’s National Health Service Must Reverse its Decision and Ensure Alzheimer’s Patients Have Access to Treatments

    Read more
  • August 01, 2024

    UsAgainstAlzheimer’s Applauds Senate Committee for $275 Million Increase in Alzheimer’s Research Funding

    Read more
  • July 31, 2024

    Nearly Half of Dementia Cases Could be Prevented or Delayed According to New Lancet Commission Report

    Read more
  • July 30, 2024

    U.S. Senate Passes Two Major Bills to Combat Alzheimer’s

    Read more
  • July 26, 2024

    European Regulators Put European Patients at Risk of Losing Groundbreaking Treatment

    Read more
  • July 02, 2024

    New Disease-Modifying Therapy Brings Good News for Early-Stage Alzheimer’s Patients

    Read more
  • June 27, 2024

    UsAgainstAlzheimer’s Applauds Approval of Bipartisan Bill to Improve Early Detection of Alzheimer's Disease

    Read more
  • June 24, 2024

    UsAgainstAlzheimer’s Board Member Wins Emmy for Alzheimer’s Documentary

    UsAgainstAlzheimer’s chair and co-founder, George Vradenburg, released the following statement in response...

    Read more
  • June 24, 2024

    Critical Question for Biden and Trump in Thursday’s Debate

    As President Joe Biden and former President Donald Trump prepare to take...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.